Sanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition

Vigil Neuroscience, Inc. (NASDAQ:VIGL) on Wednesday disclosed that it entered a deal to be acquired by Sanofi (NASDAQ:SNY) for an equity value of approximately $470 million (on a fully diluted basis). Per the terms, Sanofi will pay $8.00 per share in cash to acquire Vigil. In addition,…